• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

High cost, renal complications in diabetes management

News
Article

The cost of managing diabetes patients is extremely high, and many patients still experience poor glycemic control and renal complications, according to results of a study published online in the journal Diabetes Care.

 

The cost of managing diabetes patients is extremely high, and many patients still experience poor glycemic control and renal complications, according to results of a study published online in the journal Diabetes Care.

“The cost of caring for people with diabetes is substantial and is associated with suboptimal glycemic control, abnormal kidney function, and proteinuria,” wrote Fiona Clement, PhD, of the University of Calgary, in Calgary, Alberta, Canada, and colleagues.

The researchers compared laboratory-derived measures of glycemic control, the presence of renal complications, and the 5-year cost of caring for diabetes patients.

The authors identified 138,662 adults diagnosed diabetes as of May 1, 2004 to estimate a 5-year cost of care, which included physician visits, hospitalizations, ambulatory care, and drug costs. The researchers used linked laboratory and administrative clinical and costing data to determine the association between that 5-year cost and baseline glycemic control (HbA1c), proteinuria, and kidney function (eGFR).

The researchers determined the 5-year cost of care in Canadian dollars was $26,978 per patient, excluding drug costs. For patients 65 and older, the cost of care was $44,511, including drug costs. They noted that cost increased with worsening kidney function, presence of proteinuria, and suboptimal glycemic control (HbA1c >7.9%). Other characteristics that were linked with increasing cost included increasing age, Aboriginal status, socioeconomic status, duration of diabetes, and the presence of other illnesses.

“Future studies should assess if improvements in the management of diabetes, assessed with laboratory-derived measurements, result in cost reductions,” Dr Clement and colleagues concluded.

Related Videos
Video 2 - "Addressing Coexisting Conditions: Keys to Comprehensive Diabetes Care"
Video 1 - "The Influence of Social Determinants of Health on Diabetes Care and Outcomes"
Video 6 - "Failing to Reach Ideal Diabetes Care: Equitable Doesn’t Mean Equal"
Video 5 - "Revising Diabetes Outcome Measures"
Video 10 - "Managing Self Care"
Video 3 - "Embracing and Improving Access to Technology Tools"
Video 8 - "Demographic Differences That Impact Care"
Video 7 - "Gaps in Diabetes Education and Self Efficacy"
Video 6 - "Key Takeaways and Unmet Needs in Diabetes Treatment"
Video 5 - "Allocation of Investment and Value-Based Arrangements in Diabetes Care "
Related Content
© 2024 MJH Life Sciences

All rights reserved.